Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 91, 498-504
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research
This publication has 49 references indexed in Scilit:
- Avolition and expressive deficits capture negative symptom phenomenology: Implications for DSM-5 and schizophrenia researchClinical Psychology Review, 2011
- The evolution of depression and suicidality in first episode psychosisActa Psychiatrica Scandinavica, 2010
- To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markersBrain, Behavior, and Immunity, 2009
- Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic ConnectivityBiological Psychiatry, 2009
- Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography StudyBiological Psychiatry, 2008
- Does minocycline have antidepressant effect?Biomedicine & Pharmacotherapy, 2008
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative ReviewBiological Psychiatry, 2008
- The Structure of Negative Symptoms Within Schizophrenia: Implications for AssessmentSchizophrenia Bulletin, 2005
- The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled studyInternational Clinical Psychopharmacology, 2004
- A depression rating scale for schizophrenicsSchizophrenia Research, 1990